Patient Assessment and Management Flashcards

1
Q

What are the potential barriers to successful use of anticoag medication and management.

A
financial hardship
transportation
 literacy
 health literacy
communication
language barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what anticoagulants can be used in pregnancy?

A

UFH
(LMWH over UFH except during the final wks of pregnancy for fast reversal for delivery)

Less info on Fonda/argatroban/danaparoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why cant you use warfarin in pregnancy

A

crosses the placenta and can cause miscarriage’s, embryopathy (early exposure), Fetal bleeding, Intracranial hemorrhage (late exposure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why cant you use DOAC in pregnancy (what can it cause)

A

Miscarriages, embryopathy (facial dimorphism, limb deformity, cardiac defect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

when do you switch from LWMH to UFH when pregnant

A

at 36-37 wk gestation, to minimize the risk, or stop LMWH 24 hours prior to delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what anticoagulants can be used while breastfeeding

A

LMWH, UFH, Fonda, Warfarin

DO NOT USE DOAC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pradaxa is the only DOAC that can be used in Children in what ages and for what indication has it been FDA approved

A

children 3 months to less than 12 years old with venous thromboembolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the preferred anticoagulation therapy in children

A

LMWH Fragmin (Dalteparin ONLY one FDA approved)

although unfractionated heparin and warfarin remain frequently used. Other anticoagulants, including fondaparinux, direct thrombin inhibitors, and the newer target-specific oral anticoagulants are also discussed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the advantages of using DOAC in children

A

oral dosage formulations, including oral suspension; minimal laboratory monitoring; predictable pharmacokinetics; and no food interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Preferred anticoagulant in elderly pts greater than 75

A

apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the preferred Anticoagulant in pts with hepatic failure

A

warfarin

Then can consider dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the preferred anticoagulant in pts with renal failure

A

Unfractionated heparin (UFH)

can consider apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the ISI when calculating INR?

A

ISI indicates how particular a batch of tissue factor compares to an international reference tissue factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does POC vs Venous testing affect the correlation between INR values

A

It loses correlation once INR is over 4 (or per manufacturer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define Prothrombin time (PT)

A

measures the time it takes plasma to clot when exposed to tissue factor (which assesses the extrinsic and common pathways of coagulation. Its performed by recalcifying citrated patient plasma in the presence of tissue factor and phospholipid and determining the time it takes to form a fibrin clot. The formation of a fibrin clot is detected by visual, optical, or electromechanical methods. The result is measured in seconds and reported along with a control value and/or an INR.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what can an INR result be useful for?

INR is standardized and can be evaluated regardless of time/location

A

evaluation of bleeding in patient/ warfarin monitoring
assessment of liver synthetic function
Disseminated intravascular coagulation (DIC) is a serious disorder in which the proteins that control blood clotting become overactive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what can prolong the INR

A

warfarin, DOACs, heparins, Vit K deficiency, liver disease, DIC, APLS HCT greater than 55%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define Activated partial thromboplastin time (aPTT)

(not standardized - location specific)

A

measures the time it takes plasma to clot when exposed to substances that activate the contact factors, which assesses the intrinsic and common pathways of coagulation. It is performed by recalcifying citrated plasma in the presence of a thromboplastic material that does not have tissue factor activity (hence the term partial thromboplastin) and a negatively charged substance (eg, celite, kaolin [aluminum silicate], silica), which results in contact factor activation, thereby initiating coagulation via the intrinsic clotting pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

For heparin monitoring aPTT range should be what?

A
  1. 2-0.4 units/mL by protamine or

0. 3-0.7 anti-factor Xa units/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is aPTT used for

A

Evaluating bleedign, DIC, UFH monitoring or DTI monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what can prolong aPTT

A

DIC, vWB (von wildebrand factor), hemophilia A (def FVIII), and B (FIX), oritavacin (binds phospholipids), Lupus anticoag type inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
Definite TT (Thrombin time) 
(not for initial screening but can be used to eval pts with prolonged PT and aPTT, inherited fibrinogen disorder)
A

measures the final step of coagulation, the conversion of fibrinogen to fibrin. It is performed by incubating citrated plasma in the presence of dilute thrombin (bovine [cow] or human) and measuring the time to clot formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What can prolong TT (thrombin time)?

A

Heparin, LMWH, Bilval, argatroban, acquired fibronioge disorders, DIC, liver disease, hypoalbuminemia, paraproteinemias, bovine thrombin exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is Anti-Xa assay performed?

A

adding patient plasma to reagent factor Xa and measuring the activity of factor Xa using an artificial factor Xa substrate that releases a colored compound when cleaved (ie, chromogenic assay) but NOT chromogenic factor Xa level!

Must be calibrated for specific agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when do you use chromogenic assay of factor X

A

to monitor patients with antiphospholipid antibodies or other inhibitors that might interfere with INR. Or in patients on concurrent direct thrombin inhibitors that might interfere with INR

26
Q

what does a heparin assay measure

A

indirectly measures the amount of heparin in a person’s blood by measuring its inhibition of factor Xa activity, one of the proteins involved in blood clot formation (known as heparin anti-Xa activity).

27
Q

what does a hemoccult test measure?

A

that’s used to detect the presence of occult blood in your stool. Occult blood is blood in your stool that you can’t see in the toilet or on the toilet paper after you have a bowel movement. The hemoccult test is predominantly used as a diagnostic tool for colorectal cancer.

28
Q

what does a hematocrit measure

A

measurement of the size and number of RBCs

29
Q

what does a hemoglobin measure?

A

iron containing oxygen treansport metalloprotein in RBC

30
Q

what does a d-dimer measure

A

measures D-dimer, which is a protein fragment that your body makes when a blood clot dissolves in your body. D-dimer is normally undetectable or only detectable at a very low level unless your body is forming and breaking down significant blood clots

31
Q

What can increase levels of D-Dimer?

A
Arterial thrombosis (MI/Stroke/acute limb ischemia, afib, intracardiac thrombus) VTE, DIC, preeclampsia, use of thrombolytics 
CV Disease (HF) 
severe infection 
surgery/trauma, 
SIRS
sickle cell 
cancer 
renal disease 
normal pregnancy 
venous malformations
32
Q

what is the cut off for neutropenia ANC less than ___

A

500

33
Q

what is ANC (absolute neutrophil count)

A

estimate of the bodys ability to fight infections

{(% neutrophils + bands) x WBC}/100

34
Q

what tests do you use to monitor warfarin

A

PT/INR or factor X chromogenic assay if baseline INR is prolonged

35
Q

what tests do you use to monitor Heparin (UFH)

vs (LMWH)

A

UFH: aPTT or anti Xa (good if prolonged baseline aPTT)
LMWH: dont require montioring but if you do you can do anti Xa levels calibrated and 4 hours after 3rd-4th dose of LMWH

36
Q

what tests do you use to monitor argatroban?

A

aPTT (could use ECT)

37
Q

what tests do you use to monitor dabigatran?

A

TT (thrombin time) or ECT

38
Q

what tests do you use to monitor Apixaban, Rivaroxaban, Edoxaban?

A

Anti-Xa assay calibrated

39
Q

what is the normal, therapeutic and critical value of PT

A

normal: 10-12 or 11-13 seconds
therapeutic: 2x normal value
critical > 36 seconds

40
Q

what is the normal, therapeutic and critical value INR

A

normal: 1
therapeutic: 2-3 or 2.5-3.5
critical 4.9

41
Q

what is the normal, therapeutic and critical value aPTT

A

normal: 21-35 seconds
therapeutic 1.5-2.5 x normal
critical:100 seconds

42
Q

what is the normal, therapeutic and critical value Heparin

A

Therapeutic: 0.3 to 0.7 U/mL

Critical 1.5 Upper limit

43
Q

what is the normal, therapeutic and critical value Anti-XA for heparin

A

For Heparin
therapeutic:0.6-1.0 units/mL
critical is any above 1

44
Q

when should you collect anti Xa level when pt is receiving LMWH?

A

4hours after 3rd-4th dose of LMWH

45
Q

when should you collect anti Xa level when pt is receiving apixaban? (peak vs trough)

A

2-4 hours after a dose (PEAK)

right before next dose for (TROUGH)

46
Q

what should the trough level be for LMWH when measuring antic -Xa levels

A

less than 0.5 units/mL

higher troughs suggest impaired clearance - an increased dosing interval may be indicated

47
Q

when should you measure factor Xa assay for pts on apixaban, dabi, Riva etc?

A
  • assure absence of drug prior to invasive procedures
  • assure absence of drug prior to use of thrombolytic therapy

(Not for compliance, possible overanticoag in cases of hemorrhage, or under anticoag in cases of treatment failure)

48
Q

what is the therapeutic range for chromogenic facotor X (CHRF 10)

A

INR of 2-3.5

CFX 35%-25%

49
Q

what is peak value and trough value of Dabigatran ASSY (DABIGL or dilute thrombin time)

A

peak: 64-443ng/ml
trough: 31 -225ng/ml

50
Q

when would you use TTPAT (thrombin time to dectect direct thrombin inhibtors and DOXAS (direct Xa inhibitor scree) to detect presence of absence of direct Xa inhibitors>

A

assure absence of drugs prior to invasive procedures

assure absence of drugs prior to use of thrombolytic therapy

51
Q

what are the therapeutic ranges for DTIs -argatroban and bivalirudin: (using the aPTT)

A

argatroban: 60-100 seconds
bivalirudin: 60-90 seconds

52
Q

what are the PEAK and TROUGH values for Rivaroxaban using the RIVAR1 assay ( to measure anti-Xa levels)

both given 20mg daily
AFIB vs VTE

A

AFIB
Peak: 160-360
Trough: 4-96

VTE:

peak: 175-360
trough: 19-60

53
Q

Rapid INR (at home point of care testing is not recommended for why type of patients?

A
  1. initiating warfarin and have not reached steady state
  2. variable responses to warfarin
  3. INR goal greater than 3.5
  4. LVAD
  5. HD pts
  6. cardioversion/ablation pts (weekly INR)
  7. pts with acute or chronic inflammatory conditions
  8. advance malignancy
  9. exposed to DTI in the last 24 horus or heparin in 48 hours or XA inhibitors in the past 5 days
  10. Non-compliant pts
54
Q

what test would you want to preform in order to detect a hemorrhagic event?

A

CT/MRI/MRA
Glasgow coma score (only give reversal if score is greater than 7)
Age
Origin of hemorrhage
labs (antiXa, PT/INR, TT, CBC, aPTT, fibrinogen)

55
Q

what are the immediate actions to take to stop bleeding?

A

compression of arterial bleeding
tamponade of nasal cavity
insertion of Sengstaken-Blakemore tube for esophageal variceal bleeding if urgent endoscopy is not available.

56
Q

what can you do to counteract blood loss?

A

oxygen, IV fluids, blood transfusion

57
Q

when do you administer tranexamic acid?

A

only for trauma related bleeding (ONLY pts that are not anticoagulated) dont use for hematuria cause it can cause clots

58
Q

In patients with intracerbral hematoma(hemorrrage) when can you restart
Heparin/LMHW?
VKA?

A

Heparin/LMWH: 2-4 days after bleeding

after 10-14 days you can restart VKA

59
Q

what are the 3 non-pharmacological methods for the prevention and treatment of thromboembolism (MOST to LEAST)

A

MOST; inferior vena cava filters
intermittent pneumatic compression (IPC)
graduated compression stockings

60
Q

what are the risk factors for anticaog induced bleeding

A
older age 
female sex
hx of bleeding 
peptic ulcer 
active cancer 
HTN
Prior stroke 
renal insufficency 
alchol abuse 
liver disease
61
Q

what are the risk factors for the development of thromboembolism?

A
age > 40
obesity
hx of VTE 
cancer 
bed rest > 5 days 
major surgery 
CHF 
Varicose veins 
Fracture (hip/leg)
estrogen treatment
stroke
multiple trauma 
childbrith 
MI